Cacti Asset Management’s Teva Pharmaceutical Industries Limited TEVA Stock Holding History

Cacti Asset Management’s Portfolio TEVA Stock Details TEVA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$351K	Hold	9,000	–	–	0.02%	65
2026 Q2	$305K	Hold	9,000	–	–	0.02%	67
2026 Q1	$271K	Hold	9,000	–	–	0.02%	67
2025 Q4	$284K	Hold	9,000	–	–	0.02%	66
2025 Q3	$165K	Sell	9,000 -1,000	-10%	-$17.6K	0.01%	67
2025 Q2	$168K	Hold	10,000	–	–	0.01%	67
2025 Q1	$151K	Hold	10,000	–	–	0.01%	69
2024 Q4	$223K	Hold	10,000	–	–	0.02%	63
2024 Q3	$177K	Hold	10,000	–	–	0.01%	69
2024 Q2	$163K	Hold	10,000	–	–	0.01%	68
2024 Q1	$166K	Hold	10,000	–	–	0.01%	69
2023 Q4	$105K	Hold	10,000	–	–	0.01%	72
2023 Q3	$102K	Hold	10,000	–	–	0.01%	72
2023 Q2	$75.3K	Hold	10,000	–	–	0.01%	73
2023 Q1	$88.5K	Hold	10,000	–	–	0.01%	73
2022 Q4	$91.2K	Hold	10,000	–	–	0.01%	73
2022 Q3	$81K	Hold	10,000	–	–	0.01%	74
2022 Q2	$75K	Hold	10,000	–	–	0.01%	77
2022 Q1	$94K	Hold	10,000	–	–	0.01%	75
2021 Q4	$80K	Hold	10,000	–	–	0.01%	73
2021 Q3	$97K	Hold	10,000	–	–	0.01%	72
2021 Q2	$104K	Hold	10,000	–	–	0.01%	72
2021 Q1	$115K	Hold	10,000	–	–	0.01%	72
2020 Q4	$96K	Hold	10,000	–	–	0.01%	73
2020 Q3	$88K	Hold	10,000	–	–	0.01%	70
2020 Q2	$127K	Hold	10,000	–	–	0.01%	66
2020 Q1	$85K	Hold	10,000	–	–	0.01%	65
2019 Q4	$100K	Sell	10,000 -10,000	-50%	-$89.3K	0.01%	69
2019 Q3	$149K	Sell	20,000 -666,543	-97%	-$5.11M	0.01%	70
2019 Q2	$6.18M	Sell	686,543 -295,739	-30%	-$3.57M	0.48%	27
2019 Q1	$15.4M	Buy	982,282 +404,378	+70%	+$7.13M	1.24%	25
2018 Q4	$8.91M	Buy	577,904 +64,180	+12%	+$1.32M	0.78%	27
2018 Q3	$10.9M	Buy	+513,724	New	+$11.9M	0.81%	27

Other funds holding TEVA

WWM

Whalen Wealth Management Las Vegas, Nevada $234M AUM 28.06% 1-Year Est. Return

GAMMA Investing Foster City, California $2.96B AUM 34.38% 1-Year Est. Return

IRC

Investors Research Corp Atlanta, Georgia $569M AUM 15.41% 1-Year Est. Return

VEM

Vann Equity Management Plano, Texas $168M AUM

MPWT

MassMutual Private Wealth & Trust Windsor, Connecticut $3.79B AUM 19.33% 1-Year Est. Return

GWM

Gilpin Wealth Management Denver, Colorado $148M AUM 25.13% 1-Year Est. Return

BAM

Byrne Asset Management Kingston, New Jersey $179M AUM 29.67% 1-Year Est. Return

EWP

Elevation Wealth Partners Santa Rosa, California $356M AUM 17.04% 1-Year Est. Return

AAG

Armstrong Advisory Group Needham, Massachusetts $1.66B AUM 13.15% 1-Year Est. Return

Cacti Asset Management's TEVA Position: Q3 2026 in Review

Cacti Asset Management held its Teva Pharmaceutical Industries Limited (TEVA) position steady in Q3 2026 at 9,000 shares worth $351K. The position accounts for 0.02% of the portfolio, ranked #65.

Cacti Asset Management first reported a position in TEVA in Q3 2018 and has held it in 33 quarters since. The position peaked at $15.4M in Q1 2019. 10 funds tracked by Wall St. Rank hold TEVA as of Q3 2026.

Cacti Asset Management held 9,000 shares of Teva Pharmaceutical Industries Limited worth $351K as of Q3 2026.
Cacti Asset Management left its Teva Pharmaceutical Industries Limited share count unchanged in Q3 2026.
Teva Pharmaceutical Industries Limited made up 0.02% of Cacti Asset Management's portfolio in Q3 2026, its #65 holding.
Cacti Asset Management first reported a position in Teva Pharmaceutical Industries Limited in Q3 2018 and has held it in 33 quarters since.
Cacti Asset Management's Teva Pharmaceutical Industries Limited position peaked at $15.4M in Q1 2019.
10 funds tracked by Wall St. Rank held Teva Pharmaceutical Industries Limited as of Q3 2026.

Based on Cacti Asset Management's 13F filing for Q3 2026, filed 1 Oct 2026.